Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/07/29/2920577/0/en/Iovance-Biotherapeutics-to-Host-Second-Quarter-and-First-Half-2024-Financial-Results-Conference-Call-and-Webcast-on-Thursday-August-8-2024.html
https://www.globenewswire.com/news-release/2024/07/19/2916075/0/en/Iovance-Biotherapeutics-Reports-Inducement-Grants-under-NASDAQ-Listing-Rule-5635-c-4.html
https://www.globenewswire.com/news-release/2024/06/28/2905771/0/en/Iovance-Biotherapeutics-Submits-Marketing-Authorization-Application-to-European-Medicines-Agency-for-Lifileucel-in-Advanced-Melanoma.html
https://www.globenewswire.com/news-release/2024/06/21/2902535/0/en/Iovance-Biotherapeutics-Reports-Inducement-Grants-under-NASDAQ-Listing-Rule-5635-c-4.html
https://www.fiercepharma.com/pharma/asco-bristol-myers-i-o-triplet-iovance-touts-paradigm-changing-amtagvi-keytruda-melanoma
https://www.globenewswire.com/news-release/2024/05/24/2888160/0/en/Iovance-Biotherapeutics-to-Present-at-Upcoming-Conferences-and-Events.html
https://www.globenewswire.com/news-release/2024/05/23/2887681/0/en/Iovance-Biotherapeutics-Announces-Clinical-Data-in-Frontline-Advanced-Melanoma-at-ASCO-2024-Annual-Meeting.html
https://www.globenewswire.com/news-release/2024/05/17/2884506/0/en/Iovance-Biotherapeutics-Reports-Inducement-Grants-under-NASDAQ-Listing-Rule-5635-c-4.html
https://www.globenewswire.com/news-release/2024/05/09/2879122/0/en/Iovance-Biotherapeutics-Reports-First-Quarter-2024-Financial-Results-and-Corporate-Updates.html
https://www.globenewswire.com/news-release/2024/05/01/2873030/0/en/Iovance-Biotherapeutics-to-Host-First-Quarter-2024-Financial-Results-Conference-Call-and-Webcast-on-Thursday-May-9-2024.html